Introduction
Adrenal lesions are incidentally observed on computerized tomography (CT) in around 1% of cases, whereas those found at autopsy in 2-10 % [1, 2] . It is therefore of great importance to characterize such lesions in oncologic patients, where the presence of an adenoma or of
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Methods
Nineteen patients with adrenal pathology (10 adenomas and 9 metastases) were studied prospectively with MR. Sixteen patients had known malignant disease demonstrated in other organs (7 in the pelvis, 5 in the breast, 3 in the rectum and 1 in the stomach). All diagnoses were histologically proven, either at surgery (n = 3), CT-guided biopsy (n = 9) or follow-up (n --7). The mean diameter was 2.2 cm for adenomas and 3.6 cm metastases.
No patient had bilateral lesions. In the seven cases who underwent follow-up, there were two metastases and five adenomas. The minimum period of follow-up was 6 months (range --6-11 months). Follow-up was per-formed both clinically and by US (n --1), CT (n = 5), M R (n = 1). All patients had undergone CT exam before M R examination, study All M R images were obtained using a 1.5-T superconsk ductive magnet (Siemens Magnetom) and a body coil. SF Preliminary scans were performed using T1-and T2-2.6 weighted SE sequences; dynamic scans were then performed on the lesion plan by means of coronal G E 2.~ sequences, both before and after i.v. injection of 0.1 mmol/kg of Gadolinium diethylenetriamine-2.2 pentaacetic acid (Gd-DTPA; Schering, Berlin). SE T1-weighted sequences were obtained with a 500 ms repeti-2.0 tion time (TR) and a 15-30 ms echo time (TE) with two or four excitations; T2-weighted sequences with a T R of 1.8 2500 ms and a T E of 30 and 90 ms and 1 excitation. Slices 1.6 of 5 m m thickness were used with a 2 m m gap and imaged using a 256 x 256 matrix. In all SE sequences, a pre-satura-1A tion program was used to reduce respiratory or peristaltic artifacts.
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G E sequences were obtained during suspended respiration with an acquisition time of about 17 s. The flip angle 1.0 used was 70 ° with a T R of 50 ms and a T E of 12 ms.
SE sequences were performed in axial and coronal 0.8 planes to better demonstrate the lesion and its size, whereas G E sequences were mainly performed in the coronal 0.6 plane to reduce respiratory and peristaltic motion artifacts.
The dynamic study was performed with G E sequences on a plane pre-selected on the previous SE study where the lesion diameter was greater. G d -D T P A was injected at a dose of 0.1 mmol/kg, followed by 50 cc saline, and consecutive G E scans were performed 1, 2, 3, 4, 5, 6, 8, 10, 12, and 15 min after the G d -D T P A injection.
For the assessment of the dynamic study the mean signal intensities, both inside the adrenal mass and the subcutaneous fat were recorded. Inside the lesion, the greatest possible region of interest, (ROI), compatible with the lesion to be measured was used, avoiding borderline areas to minimize the influence of the partial-volume effect. To evaluate the signal intensity of fat, the size of the R O I measurement was always 1.5 cm.
The signal intensity ratio between the lesion and retroperitoneal fat (SL/SF) was calculated in all sequences ob- 
Results
All adenomas gave a low signal intensity on Tl-weighted images when using an SE sequence, while on T2-weighted sequences, signal intensity was low in eight cases and slightly hyperintense in two cases. Metastases appeared hypointense on SE T1-and hyperintense on SE T2-weighted sequences in all cases. By means of the G E sequences, signal intensities from lesions were recorded before and after G d -D T P A injection.
In scans performed in baseline conditions, metastases showed SL/SF ratios between 0.6 and 0.9, whereas adenomas showed values between 0.3 and 0.6. In one patient alone was the SL/SF ratio for adenoma in the range found for metastatic lesions. Following G d -D T P A administration, metastases behaved substantially differently from adenomas, showing a quick and progressive enhancement with peak values between 1.7 and 2.1, after 2-3 min. Enhancement remained high in later scans, reaching values above 1.1 after 10 rain (Fig. 1) . Only a metastasin from a rectal carcinoma showed abnormal SL/SF values (0.7, 1 min after G d -D T P A injection and 1.0, 2 min after), which were similar to that of benign lesions though in scans obtained 8 and 10 min later, the lesion showed higher values than adenomas.
Following G d -D T P A injection, adenomas showed a moderate enhancement with a peak after about 2 min In all cases a decreased enhancement was observed with values ranging between 0.7 and 0.8 after 10 rain (Fig.2 ).
There is a SL/SF cut-off point between metastases and adenomas between 1.1 and 1.2 where, in later scans (after 10 min), all metastases showed higher SL/SF values and all benign lesions lower values (Table 1) .
With G E sequences, it was possible to correctly characterize two lesions, one adenoma (Fig. 3 ) and one metastasis (Fig. 4) , that were equivocal with SE sequences, and to better define a third lesion, interpreted as "possible" metastasis with SE sequences. Only in one case, which was found to be an adenoma at biopsy, did we fail to make a correct diagnosis with either SE or G E sequences.
In one patient with breast cancer, both SE and G E sequences failed to characterize a round homogeneous mass in the right adrenal. On SE T1 sequences, the lesion was isointense with the liver, whereas the signal was partially hyperintense on T2; the dynamic study showed an adenoma-like enhancement, with a small hyperintense central area in later scans. At biopsy, it was found it to be an adenoma (Table 2 ).
D i s c u s s i o n
M R imaging of adrenal glands with SE T1-and T2-weighted sequences offers the possibility of differentiating between benign and malignant lesions. On T2-weighted images, high signal intensities are suggestive of malignant lesions [5-8, 13, 14] .
By the way there is a large n u m b e r of indeterminate findings (20-30 %) reported in different series of adrenal lesions, with a typical signal intensity of metastasis or adenoma that were not such at biopsy [5, 15] .
The aim of our study was a prospective evaluation of "conventional" SE sequences versus dynamic contrastenhanced images. With dynamic G E sequences the M R criteria for differential diagnosis is the different enhancement characteristic of benign and malignant lesions: according to the literature the former exhibit a mild enhancement and a quick washout, whereas the latter show a more pronounced enhancement and a much slower washout [10] [11] [12] .
In our series the most consistent results were obtained by comparing the relative SL/SF signal intensities in scans taken after 10 min: metastases have always showed, with respect to adenomas, a much higher SL/SF ratio. We were therefore able to correctly characterize as metastasis a mass with a low SL/SF ratio in early scans, and to recognize as an adenoma a lesion with a high SL/SF ratio after 2 rain, in a patient with Cushing's syndrome. The dynamic study after administration of G d -D T P A was in this case particularly helpful, since the lesion showed a high signal intensity on SE T2-weighted sequences. In comparison with SE T1-and T2-weighted sequences, G E with Gd-D T P A enhanced dynamic study proved to be more specific since we were able to correctly characterize 18 lesions out of 19, with an overall diagnostic accuracy of 95 %. SE sequences provided useful data for the exact classification of lesions in 16 cases out of 19, with an overall accuracy of 84 %. These data are in agreement with those of another series [11] which studied 38 cases including primary tumors and pheochromocytomas and observed a much higher diagnostic accuracy in GE sequences with Gd-DTPA versus SE sequences in the differential diagnosis of benign and malignant lesion.
In conclusion, this study reveals that MR, performed with a Gd-DTPA enhanced dynamic study, allows the characterization of adenomas and metastases with a greater accuracy compared with that of "conventional" SE sequences. We therefore believe that GE MR imaging with Gd-DTPA enhanced dynamic studies should be performed in all cases of equivocal adrenal masses.
